Targeted Elimination of Tumorigenic Human Pluripotent Stem Cells Using Suicide-Inducing Virus-like Particles.
Antonio RampoldiStephen N CrookeMarcela K PreiningerRajneesh JhaJoshua MaxwellLingmei DingPaul SpearmanNeal K DevarajChunhui XuPublished in: ACS chemical biology (2018)
Sensitization to prodrugs via transgenic expression of suicide genes is a leading strategy for the selective elimination of potentially tumorigenic human pluripotent stem cells (hPSCs) in regenerative medicine, but transgenic modification poses safety risks such as deleterious mutagenesis. We describe here an alternative method of delivering suicide-inducing molecules explicitly to hPSCs using virus-like particles (VLPs) and demonstrate its use in eliminating undifferentiated hPSCs in vitro. VLPs were engineered from Qβ bacteriophage capsids to contain enhanced green fluorescent protein (EGFP) or cytosine deaminase (CD) and to simultaneously display multiple IgG-binding ZZ domains. After labeling with antibodies against the hPSC-specific surface glycan SSEA-5, EGFP-containing particles were shown to specifically bind undifferentiated cells in culture, and CD-containing particles were able to eliminate undifferentiated hPSCs with virtually no cytotoxicity to differentiated cells upon treatment with the prodrug 5-fluorocytosine.
Keyphrases
- pluripotent stem cells
- induced apoptosis
- cell cycle arrest
- endothelial cells
- cancer therapy
- poor prognosis
- binding protein
- endoplasmic reticulum stress
- oxidative stress
- crispr cas
- gene expression
- long non coding rna
- signaling pathway
- nk cells
- induced pluripotent stem cells
- cell proliferation
- living cells
- small molecule
- climate change
- risk assessment
- transcription factor
- pi k akt
- bioinformatics analysis